6-K

Golden Sun Technology Group Ltd. (GSUN)

6-K 2024-05-07 For: 2024-05-07
View Original
Added on April 08, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934


For the month of May 2024


Commission File Number: 001-41425


Golden Sun Health Technology Group Limited


Profit Huiyin Square North Building 2F

Huashan 2018, Unit 1001

Xuhui District, Shanghai, China

(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒     Form 40-F ☐

Exhibit Index


Exhibit No. Description
99.1 Press Release - Golden Sun Health Technology Group Limited Regains Compliance with Nasdaq Continued Listing Requirement
1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: May 7, 2024

Golden Sun Health Technology Group Limited
By: /s/ Xueyuan Weng
Name: Xueyuan Weng
Title: Chief Executive Officer

2

Exhibit 99.1

Golden Sun Health Technology Group Limited RegainsCompliance with Nasdaq Continued Listing Requirement

Shanghai, China, May 7, 2024 (GLOBE NEWSWIRE) -- Golden Sun Health Technology Group Limited, formerly known as Golden Sun Education Group Limited (the “Company” or “Golden Sun”) (Nasdaq: GSUN), a provider of tutorial services in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on May 3, 2024, informing the Company that it has regained compliance with the Nasdaq’s minimum bid price requirement. According to the Notification Letter, as of May 2, 2024, Golden Sun has maintained a closing bid price of $1.00 per share for ten consecutive trading sessions following a 1 for 10 reverse stock-split on April 19, 2024.


About Golden Sun Health Technology Group Limited

Established in 1997 and headquartered in Shanghai, China, Golden Sun Health Technology Group Limited, formerly known as Golden Sun Education Group Limited, is a provider of tutorial services in China with over twenty years of experience providing educational services that focus on the development of each of its student’s strengths and potential, and the promotion of life-long skills and interests in learning. Golden Sun has three tutorial centers, one educational company that partners with high schools to offer language classes, and one logistics company that provides logistic and consulting services. The tutorial centers of Golden Sun focus on different groups of targeted students by offering different tutorial programs. For more information, visit the Company’s website at ir.jtyjyjt.com.


Forward-Looking Statements

Certain statements in this announcement areforward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’scurrent expectations and projections about future events that the Company believes may affect its financial condition, results of operations,business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “approximates,”“assesses,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,”“projects,” “intends,” “plans,” “will,” “would,” “should,” “could,”“may” or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statementsto reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although theCompany believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectationswill turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated resultsand encourages investors to review other factors that may affect its future results in the Company’s annual report and other filings withthe U.S. Securities and Exchange Commission.


For more information, please contact:


Golden Sun Health Technology Group Limited

Investor Relations Department

Email: ir@cngsun.com


Ascent Investor Relations LLC

Tina Xiao

President

Phone: +1 646-932-7242

Email: investors@ascent-ir.com